Related Experiment Video
Updated: Jul 23, 2026

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
Published on: March 5, 2018
X-linked inhibitor of apoptosis protein (XIAP) inhibits caspase-3 and -7 in distinct modes
Y Suzuki1, Y Nakabayashi, K Nakata
1Laboratory for Motor System Neurodegeneration, RIKEN-Brain Science Institute, Wako City, Saitama 351-0198, Japan.
Abstract:
The inhibitor of apoptosis proteins (IAP) regulates cell death by inhibiting caspases. The region of X-linked (X) IAP containing the second baculovirus IAP repeat domain (BIR2) is sufficient for inhibiting caspase-3 and -7. In this study, we found that the modes of inhibition of these two caspases were different: caspase-3 is inhibited in a competitive manner whereas caspase-7 inhibition occurs through a mixed competitive and noncompetitive mechanism. Binding assays revealed that the inhibition of caspase-3 by XIAP was totally dependent on the interaction between the active site of caspase-3 and the linker region between the BIR1 and BIR2 domains of XIAP. In contrast, the active site and the NH(2)-terminal region of caspase-7 bound to the linker region and the BIR2, respectively. Moreover the BIR2 with a mutated linker region, which inhibited caspase-3 very weakly, still bound to and inhibited caspase-7. Furthermore, a chimeric caspase-7/3 comprising the NH(2)-terminal portion of caspase-7 and COOH-terminal portion of caspase-3 was inhibited by XIAP by a mixed competitive and noncompetitive mechanism. Our results suggest that the linker region between BIR1 and BIR2 domains is responsible for active site-directed, competitive inhibition of both caspase-3 and -7, whereas the BIR2 itself is involved in noncompetitive inhibition of caspase-7.
Insights
The X-linked inhibitor of apoptosis protein (XIAP) inhibits caspases differently. XIAP
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Death Regulation
Background:
- Inhibitor of Apoptosis Proteins (IAP) are key regulators of programmed cell death.
- X-linked IAP (XIAP) is a potent inhibitor of caspases, crucial executioners of apoptosis.
- The BIR2 domain of XIAP is known to be sufficient for inhibiting caspases-3 and -7.
Purpose of the Study:
- To elucidate the distinct mechanisms by which XIAP inhibits caspase-3 and caspase-7.
- To identify the specific domains of XIAP responsible for differential caspase inhibition.
- To investigate the role of the linker region and BIR2 domain in XIAP-mediated caspase regulation.
Main Methods:
- Enzyme kinetics assays to determine inhibition mechanisms (competitive vs. non-competitive).
- Binding assays to map protein-protein interactions between XIAP domains and caspases.
- Site-directed mutagenesis of XIAP domains and construction of chimeric caspases.
Main Results:
- XIAP competitively inhibits caspase-3 via interaction with its active site and the XIAP linker region.
- XIAP inhibits caspase-7 via a mixed mechanism, involving both the linker region (competitive) and BIR2 domain (non-competitive).
- Mutating the XIAP linker region impaired caspase-3 inhibition but not caspase-7 inhibition.
- A chimeric caspase-7/3 construct was inhibited by XIAP using a mixed mechanism, highlighting domain contributions.
Conclusions:
- The linker region between XIAP's BIR1 and BIR2 domains mediates competitive inhibition of both caspase-3 and -7.
- The XIAP BIR2 domain contributes to the non-competitive inhibition of caspase-7.
- XIAP employs distinct domain-specific interactions to differentially regulate caspase activity, impacting cell death pathways.
Related Concept Videos
X-Inactivation
Apoptosis
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
The JAK-STAT Signaling Pathway

